HOT NEWS
Merck total revenues increase 3.2% to € 2.6 billion » The Merck Group's first-quarter 2012 total revenues rose 3.2% to € 2,645 million compared to €...
Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication i... » Abbott (NYSE: ABT) today announced that the XIENCE PRIME™ and the XIENCE V® Everolimus Eluting Co...
GSK statement on BBC Panorama broadcast: 'the truth about tax' » GSK issued the following statement in response to the BBC Panorama programme related to Corporation ...
Novartis drug Signifor® approved in the EU as the first medication to treat pat... » Novartis announced that the European Commission has approved Signifor® (pasireotide) for the treatm...
Amgen to acquire Mustafa Nevzat, a leading privately held Turkish pharmaceutical... » Amgen (NASDAQ:AMGN), the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (...
FORXIGA (dapagliflozin) receives positive CHMP opinion » AstraZeneca and Bristol-Myers Squibb Company today announced that the Committee for Medicinal Produc...
Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative Co... » Abbott today announced that the European Commission has approved HUMIRA® (adalimumab) for the treat...
Novartis QVA149 Phase III COPD studies meet primary endpoints » The first three Novartis QVA149 Phase III studies in the treatment of chronic obstructive pulmonary ...
BYETTA® approved for use with basal insulin in Europe » Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the...
GSK reinforces commitment to youth training » GSK announced the launch of a new multi-disciplinary apprenticeship scheme. The programme, which wil...
Newsfeeds
Abbott.com
Press Releases

Bookmark and Share

Banner